Piper Sandler is acting as sole book running manager for the offering.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on OKYO:
- OKYO Pharma Launches Public Offering to Fund Next Phase of Corneal Pain Drug Development
- Okyo Pharma announces ordinary shares offering, no amount given
- OKYO Pharma Switches ATM Equity Facility to Leerink Partners to Support Urcosimod Push
- OKYO Pharma Launches $50 Million At-the-Market Share Offering With Leerink Partners
- OKYO Pharma Hires Oxervate Veteran Flavio Mantelli as Chief Medical Officer to Drive Urcosimod Program